Goldman Sachs
NEO icon

Goldman Sachs’s NeoGenomics NEO Stock Holding History

Goldman Sachs’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.45M Sell
1,003,623
-429,507
-30% -$4.52M ﹤0.01% 3320
2025
Q4 		$16.9M Sell
1,433,130
-371,264
-21% -$4.01M ﹤0.01% 2548
2025
Q3 		$13.9M Buy
1,804,394
+320,127
+22% +$2.24M ﹤0.01% 2636
2025
Q2 		$10.8M Sell
1,484,267
-232,453
-14% -$1.88M ﹤0.01% 2685
2025
Q1 		$16.3M Sell
1,716,720
-574,287
-25% -$7.17M ﹤0.01% 2225
2024
Q4 		$37.8M Sell
2,291,007
-194,625
-8% -$3.02M 0.01% 1537
2024
Q3 		$36.7M Buy
2,485,632
+394,355
+19% +$6.17M 0.01% 1507
2024
Q2 		$29M Sell
2,091,277
-226,181
-10% -$3.21M ﹤0.01% 1562
2024
Q1 		$36.4M Buy
2,317,458
+30,313
+1% +$468K 0.01% 1375
2023
Q4 		$37M Sell
2,287,145
-179,991
-7% -$2.95M 0.01% 1395
2023
Q3 		$30.3M Sell
2,467,136
-53,542
-2% -$796K 0.01% 1447
2023
Q2 		$40.5M Buy
2,520,678
+55,401
+2% +$913K 0.01% 1260
2023
Q1 		$42.9M Sell
2,465,277
-312,721
-11% -$4.45M 0.01% 1173
2022
Q4 		$25.7M Buy
2,777,998
+128,082
+5% +$1.19M 0.01% 1732
2022
Q3 		$22.8M Sell
2,649,916
-765,479
-22% -$7.6M 0.01% 1755
2022
Q2 		$27.8M Buy
3,415,395
+2,973,739
+673% +$28.4M 0.01% 1622
2022
Q1 		$5.37M Sell
441,656
-66,201
-13% -$1.39M ﹤0.01% 3290
2021
Q4 		$17.3M Buy
507,857
+269,139
+113% +$10.5M ﹤0.01% 2259
2021
Q3 		$11.5M Buy
238,718
+3,040
+1% +$141K ﹤0.01% 2591
2021
Q2 		$10.6M Sell
235,678
-57,938
-20% -$2.57M ﹤0.01% 2633
2021
Q1 		$14.2M Buy
293,616
+95,696
+48% +$4.98M ﹤0.01% 2246
2020
Q4 		$10.7M Sell
197,920
-76,133
-28% -$3.44M ﹤0.01% 2402
2020
Q3 		$10.1M Sell
274,053
-183,749
-40% -$6.83M ﹤0.01% 2313
2020
Q2 		$14.2M Sell
457,802
-150,118
-25% -$4.16M ﹤0.01% 1968
2020
Q1 		$16.8M Buy
607,920
+210,655
+53% +$6.31M 0.01% 1646
2019
Q4 		$11.6M Buy
397,265
+79,040
+25% +$1.88M ﹤0.01% 2324
2019
Q3 		$6.08M Buy
318,225
+35,258
+12% +$827K ﹤0.01% 2708
2019
Q2 		$6.21M Sell
282,967
-3,193
-1% -$70.1K ﹤0.01% 2698
2019
Q1 		$5.86M Buy
286,160
+89,715
+46% +$1.56M ﹤0.01% 2845
2018
Q4 		$2.48M Buy
196,445
+152,649
+349% +$2.27M ﹤0.01% 3400
2018
Q3 		$672K Sell
43,796
-12,852
-23% -$178K ﹤0.01% 4254
2018
Q2 		$743K Buy
56,648
+13,781
+32% +$152K ﹤0.01% 4268
2018
Q1 		$350K Buy
42,867
+3,248
+8% +$26.3K ﹤0.01% 4701
2017
Q4 		$351K Sell
39,619
-17,951
-31% -$166K ﹤0.01% 5076
2017
Q3 		$641K Buy
57,570
+26,892
+88% +$262K ﹤0.01% 4916
2017
Q2 		$275K Buy
30,678
+13,561
+79% +$108K ﹤0.01% 5575
2017
Q1 		$135K Sell
17,117
-2,520
-13% -$20.5K ﹤0.01% 5929
2016
Q4 		$168K Sell
19,637
-3,670
-16% -$31.4K ﹤0.01% 5886
2016
Q3 		$192K Buy
23,307
+8,668
+59% +$72.7K ﹤0.01% 5855
2016
Q2 		$118K Buy
+14,639
New +$117K ﹤0.01% 6043
2015
Q4 		– Sell
-137,038
Closed -$785K – 7279
2015
Q3 		$785K Buy
137,038
+110,930
+425% +$687K ﹤0.01% 4707
2015
Q2 		$141K Sell
26,108
-57,196
-69% -$295K ﹤0.01% 6418
2015
Q1 		$389K Buy
83,304
+56,158
+207% +$244K ﹤0.01% 5383
2014
Q4 		$113K Sell
27,146
-14,188
-34% -$65.2K ﹤0.01% 6527
2014
Q3 		$215K Buy
41,334
+21,304
+106% +$109K ﹤0.01% 6092
2014
Q2 		$66K Buy
+20,030
New +$66.6K ﹤0.01% 6688

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Goldman Sachs's NEO Position: Q1 2026 in Review

Goldman Sachs reduced its NeoGenomics (NEO) stake by 30% in Q1 2026, selling an estimated $4.52M and leaving 1,003,623 shares worth $7.45M. The position accounts for ﹤0.01% of the portfolio, ranked #3320.

Goldman Sachs first reported a position in NEO in Q2 2014 and has held it in 46 quarters since. The position peaked at $42.9M in Q1 2023. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Goldman Sachs held 1,003,623 shares of NeoGenomics worth $7.45M as of Q1 2026.
  • Goldman Sachs sold 429,507 NeoGenomics shares in Q1 2026, an estimated $4.52M.
  • NeoGenomics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #3320 holding.
  • Goldman Sachs first reported a position in NeoGenomics in Q2 2014 and has held it in 46 quarters since.
  • Goldman Sachs's NeoGenomics position peaked at $42.9M in Q1 2023.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.